Merck no longer in talks to buy Revolution Medicines, WSJ reports
25/01/2026 19:47
Jan 25 (Reuters) - Merck MRK.N is no longer in discussions to buy Revolution Medicines RVMD.O, the Wall Street Journal reported on Sunday, citing people familiar with the matter. Reuters could not immediately verify the report. (Reporting by Mihika Sharma in Bengaluru; Editing by Andrew Heavens) ((Mihika.Sharma@thomsonreuters.com;))
Recent news on Revolution Medicines
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
Brief: CHMP Recommends Granting Marketing Authorisation For Rasonque For Metastatic Pancreatic Cancer In EU
Revolution Medicines wins EU committee backing for pancreatic cancer treatment (updated)
EMA recommends approval of Revolution's pancreatic cancer drug
Revolution Medicines falls on pancreatic cancer drug data concerns